Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Regeneron Pharmaceuticals
David M Brown; David S Boyer; Diana V Do; Charles C Wykoff; Taiji Sakamoto; Peter Win; Sunir Joshi; Hani Salehi-Had; András Seres; Alyson J Berliner; Sergio Leal; Robert Vitti; Karen W Chu; Kimberly Reed; Rohini Rao; Yenchieh Cheng; Wei Sun; Delia Voronca; Rafia Bhore; Ursula Schmidt-Ott; Thomas Schmelter; Andrea Schulze; Xin Zhang; Boaz Hirshberg; George D Yancopoulos; Sobha Sivaprasad; PHOTON Investigators